Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 2

Conditions

Mesothelioma, Malignant 2

Interventions

Carboplatin 41Cisplatin 40Paclitaxel 35Radiotherapy 32Docetaxel 19Pemetrexed 18Gemcitabine 17Etoposide 17Bevacizumab 11Radiosurgery 10Magnetic Resonance Spectroscopy 9Ramucirumab 8durvalumab 7Taxes 7Cetuximab 7pembrolizumab 6Specimen Handling 6Erlotinib Hydrochloride 6Irinotecan 5Gene Expression Profiling 5Filgrastim 5cediranib 4Vinorelbine 4Polymerase Chain Reaction 4Neoadjuvant Therapy 4Fluorodeoxyglucose F18 4Chemotherapy, Adjuvant 4Amplified Fragment Length Polymorphism Analysis 4tremelimumab 3osimertinib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × raltitrexed × Thoracic × Clear all
NCT00004254 2012-07-18

Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
25 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT00004920 2012-07-18

Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Completed
256 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡